CMS announced massive price reductions for 15 critical drugs, including Xtandi, Ibrance, and Janumet. See the full list and ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe Biden back in 2022: the Inflation Reduction Act, which allowed the CMS to ...

The federal government says it has struck a deal to dramatically lower prices on 15 widely used medications covered by Medicare, a list that includes some of the most recognizable ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The Centers for Medicare & Medicaid Services extended a safety net to older Americans by announcing significant price ...

The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.

There is no sole Medicare drug price list currently available, as medication costs and availability can vary according to the company administering a Part D prescription drug plan. A person must ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...